Bill

Bill > LD2201


ME LD2201

ME LD2201
An Act to Implement Certain Recommendations Related to the Regulatory Review and Approval of Certain Health Care Transactions Involving Private Equity Companies, Hedge Funds or Management Services Organizations from the Commission to Evaluate the Scope of Regulatory Review and Oversight over Health Care Transactions That Impact the Delivery of Health Care Services in the State


summary

Introduced
02/10/2026
In Committee
02/10/2026
Crossed Over
Passed
Dead

Introduced Session

132nd Legislature

Bill Summary

This bill is reported out by the Joint Standing Committee on Health Coverage, Insurance and Financial Services pursuant to Resolve 2025, chapter 106 to implement a recommendation from the Commission to Evaluate the Scope of Regulatory Review and Oversight over Health Care Transactions That Impact the Delivery of Health Care Services in the State. The joint standing committee has not taken a position on the substance of this bill. By reporting this bill out, the joint standing committee is not suggesting and does not intend to suggest that it agrees or disagrees with any aspect of this bill; instead, the joint standing committee is reporting the bill out for the sole purpose of having a bill printed that can be referred to a joint standing committee for an appropriate public hearing and subsequent processing in the normal course. The joint standing committee is taking this action to ensure clarity and transparency in the legislative review of the proposals contained in the bill. This bill establishes a process for review and approval of transactions when a private equity company, hedge fund or management services organization acquires a majority ownership interest in a health care entity or when a private equity company, hedge fund or management services organization takes operational control over a health care entity.

AI Summary

This bill establishes a new process for reviewing and approving significant changes in the ownership or operational control of healthcare entities in Maine when these changes involve private equity companies, hedge funds, or management services organizations. A "material change transaction" is defined as an acquisition of majority interest or operational control over a healthcare entity by one of these types of investors. Healthcare entities must provide at least 180 days' notice to the state department before completing such a transaction, detailing the terms, goals, and impact on healthcare services. The department will then conduct a preliminary review, which may lead to outright approval, conditional approval, or a more comprehensive review if the transaction involves assets over $100 million, could lessen competition, or is deemed likely to materially impact the cost, quality, equity, or access to healthcare services. This comprehensive review involves public hearings and an analysis by the Office of Affordable Health Care, considering factors like service quality, patient concerns, pricing, workforce impact, and market share. The department has the authority to approve, conditionally approve, or disapprove these transactions, and enforcement mechanisms are in place for violations, including potential administrative penalties and post-transaction oversight. Additionally, the bill mandates annual reporting on the ownership and control of healthcare entities to improve transparency, with certain exceptions for small physician groups.

Committee Categories

Health and Social Services

Sponsors (0)

No sponsors listed

Last Action

Voted: OTP-AM (on 02/25/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...